Alsaleh Saad, Kamal Nehal, Hopkins Claire, Al Rand Hussain, Marglani Osama A, Alterki Abdulmohsen, Abu Suliman Omar, Alandejani Talal, Kamel Reda, Al Abri Rashid, Alotaibi Naif H, Al Amadi Ahmad, Bahakim Abdullah, Han Joseph K, Javer Amin, Sedaghat Ahmad R, Gevaert Philippe
Department of Otolaryngology-Head and Neck Surgery, College of Medicine King Saud University Riyadh Saudi Arabia.
Global Medical Immunology - Specialty Care Sanofi United Arab Emirates.
Laryngoscope Investig Otolaryngol. 2024 May 27;9(3):e1277. doi: 10.1002/lio2.1277. eCollection 2024 Jun.
Chronic rhinosinusitis (CRS) is a heterogeneous disorder with a wide range of validated subjective and objective assessment tools to assess disease severity. However, a comprehensive and easy-to-use tool that integrates these measures for determining disease severity and response to treatment is still obscure. The objective of this study was to develop a standardized assessment tool that facilitates diagnosis, uniform patient monitoring, and comparison of treatment outcomes between different centers both in routine clinical practice and in research.
To develop this tool, published literature on assessment tools was searched on various databases. A panel of 12 steering committee members conducted an advisory board meeting to review the findings. Specific outcome measures to be included in a comprehensive assessment tool and follow-up sheet were then collated following consensus approval from the panel. The tool was further validated for content and revised with expert recommendations to arrive at the finalized Nasal Polyp Patient Assessment Scoring Sheet (N-PASS) tool.
The N-PASS tool was developed by integrating the subjective and objective measures for CRS assessment. Based on expert opinions, N-PASS was revised to be used as an easy-to-use guidance tool that captures patient-reported and physician-assessed components for comprehensively assessing disease status and response to treatment.
The N-PASS tool can be used to aid in the diagnosis and management of CRS cases with nasal polyps. The tool would also aid in improved monitoring of patients and pave the way for an international disease registry.
Oxford Level 3.
慢性鼻-鼻窦炎(CRS)是一种异质性疾病,有多种经过验证的主观和客观评估工具来评估疾病严重程度。然而,一种整合这些措施以确定疾病严重程度和治疗反应的全面且易于使用的工具仍不明确。本研究的目的是开发一种标准化评估工具,以促进在常规临床实践和研究中进行诊断、统一的患者监测以及不同中心之间治疗结果的比较。
为开发此工具,在多个数据库中搜索了关于评估工具的已发表文献。由12名指导委员会成员组成的小组召开了咨询委员会会议以审查研究结果。在小组达成共识批准后,整理了综合评估工具和随访表中应包含的具体结果指标。该工具进一步进行了内容验证,并根据专家建议进行修订,最终形成了鼻息肉患者评估评分表(N-PASS)工具。
N-PASS工具是通过整合CRS评估的主观和客观指标而开发的。根据专家意见,N-PASS经过修订,用作一种易于使用的指导工具,涵盖患者报告和医生评估的内容,以全面评估疾病状态和治疗反应。
N-PASS工具可用于辅助诊断和管理伴有鼻息肉的CRS病例。该工具还将有助于改善对患者的监测,并为建立国际疾病登记册铺平道路。
牛津3级。